Ascendis Pharma A/S (Ascendis Pharma A/S) Other Long Term Assets : $2.3 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma A/S Other Long Term Assets?

Ascendis Pharma A/S's other long-term assets for the quarter that ended in Dec. 2023 was $2.3 Mil.

Ascendis Pharma A/S's quarterly other long-term assets increased from Jun. 2023 ($2.2 Mil) to Sep. 2023 ($2.3 Mil) and increased from Sep. 2023 ($2.3 Mil) to Dec. 2023 ($2.3 Mil).

Ascendis Pharma A/S's annual other long-term assets declined from Dec. 2021 ($2.0 Mil) to Dec. 2022 ($2.0 Mil) but then increased from Dec. 2022 ($2.0 Mil) to Dec. 2023 ($2.3 Mil).

Ascendis Pharma A/S Other Long Term Assets Historical Data

The historical data trend for Ascendis Pharma A/S's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Other Long Term Assets Chart

Ascendis Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

1.63

1.67

2.04

2.03

2.32

Ascendis Pharma A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															2.03	2.13	2.24	2.29	2.32

Ascendis Pharma A/S Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

http://www.ascendispharma.com

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.